Tag: Sotatercept

In 2021, there were an estimated 192,000 cases of pulmonary arterial hypertension (PAH) globally [1.6.2]. The critical question for patients and clinicians is, **what is the best medication for pulmonary arterial hypertension?** The answer lies in a personalized, multi-faceted approach.

According to data from clinical trials like STELLAR, a significant percentage of patients taking Winrevair reported experiencing side effects, most commonly headache and nosebleeds. This article details what are the side effects of the drug Winrevair, both common and severe, to help patients and caregivers understand the potential risks associated with this pulmonary arterial hypertension (PAH) treatment.